Our Focus

Cancer Control Research (CCR) conducts internationally recognized research on cancer etiology, prevention and surveillance; screening and early detection; diagnosis, treatment and supportive care; through to rehabilitation and survivorship.

CCR

This includes research into the epidemiological, biological, behavioral, social determinants of cancer risk; cancer surveillance and early detection; evidence based medicine, clinical trials research and real world effectiveness; improving patient satisfaction and health outcomes; precision medicine and its impact on society; patient and public engagement; the cost-effectiveness of cancer interventions; and cancer survivorship.

The Department is a critical part of the Learning Health System in BC. It directly supports BC Cancer by integrating population based research within BC’s population based comprehensive cancer control program.

Programs and Platform & Principal Investigators

News & Events

Exploring inequities in access to life-saving genetic testing for patients with advanced ovarian cancer

A pan-Canadian research team led by Dr. Helen McTaggart-Cowan, a BC Cancer scientist, will receive $183,500 through a new Patient Voices in Research Initiative from the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network (the Network) to examine barriers to accessing homologous recombination deficiency (HRD) testing for patients with advanced ovarian cancer.

New study explores patient preferences to improve data sharing for precision oncology across Canada

In a new study, a team led by Dr. Dean Regier, Senior Scientist in Cancer Control at BC Cancer and co-chair of the MOHCCN Health Technology Assessment Working Group, conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns for enhanced data sharing.

Recent Publications

Back to top